CN Patent

CN104840965B — 波生坦的制剂及其稳定剂

Assigned to Chongqing Huapont Pharm Co Ltd · Expires 2018-05-08 · 8y expired

What this patent protects

本发明属于药物制剂领域，特别涉及波生坦药物制剂的组合物，该组合物包含波生坦、一水乳糖、微晶纤维素KG802，十二烷基硫酸钠或吐温‑80。所述组合物增加了波生坦的溶出度，提高了制剂晶型稳定性。该组合物可制备成片剂、胶囊剂、颗粒剂等固体口服制剂，制备方法简单、可行、易于实现产业化大生产。

USPTO Abstract

本发明属于药物制剂领域，特别涉及波生坦药物制剂的组合物，该组合物包含波生坦、一水乳糖、微晶纤维素KG802，十二烷基硫酸钠或吐温‑80。所述组合物增加了波生坦的溶出度，提高了制剂晶型稳定性。该组合物可制备成片剂、胶囊剂、颗粒剂等固体口服制剂，制备方法简单、可行、易于实现产业化大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104840965B
Jurisdiction
CN
Classification
—
Expires
2018-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Huapont Pharm Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.